Ultrasonographic Muscles and Fascia Measurement With Myofascial Pain Syndrome

Sponsor

Bursa Yüksek İhtisas Education and Research Hospital (Other)

Overall Status

Not yet recruiting

CT.gov ID

NCT05359523

Collaborator

(none)

Enrollment

Arms

Anticipated Duration (Months)

Study Details

Study Description

Brief Summary

Pathologies in the trapezius muscle and rhomboid muscle are important in the course and treatment of the disease in patients with myofascial pain syndrome.

Condition or Disease	Intervention/Treatment	Phase
Myofascial Pain Syndrome	Device: Ultrasonographic measurements of the trapezius and rhomboid muscle and fascia	N/A

Detailed Description

In this study, the role of the thickness of these muscles and the shift during movement in the activity and diagnosis of the disease in myofascial pain syndrome will be investigated.

Study Design

Study Type:

Interventional

Anticipated Enrollment :

60 participants

Allocation:

Non-Randomized

Intervention Model:

Parallel Assignment

Masking:

Single (Investigator)

Primary Purpose:

Diagnostic

Official Title:

Investigation of the Diagnostic Effect of Ultrasonographic Measurement Values of Upper Back Muscles and Fascia in Patients With Myofascial Pain Syndrome

Anticipated Study Start Date :

May 1, 2022

Anticipated Primary Completion Date :

Jul 1, 2022

Anticipated Study Completion Date :

Aug 1, 2022

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Patients diagnosed with myofascial pain syndrome Ultrasound measurements will be made while the upper back is at rest and during arm movements.	Device: Ultrasonographic measurements of the trapezius and rhomboid muscle and fascia B mode measurements Trapezius and rhomboid muscle thickness and fascial thickness measurement M mode measurements Abduction at 90 and 180 degrees Forward flexion at 90 and 180 degrees
Active Comparator: Healthy volunteers Ultrasound measurements will be made while the upper back is at rest and during arm movements.	Device: Ultrasonographic measurements of the trapezius and rhomboid muscle and fascia B mode measurements Trapezius and rhomboid muscle thickness and fascial thickness measurement M mode measurements Abduction at 90 and 180 degrees Forward flexion at 90 and 180 degrees

Arm

Intervention/Treatment

Active Comparator: Patients diagnosed with myofascial pain syndrome

Ultrasound measurements will be made while the upper back is at rest and during arm movements.

Device: Ultrasonographic measurements of the trapezius and rhomboid muscle and fascia

B mode measurements Trapezius and rhomboid muscle thickness and fascial thickness measurement M mode measurements Abduction at 90 and 180 degrees Forward flexion at 90 and 180 degrees

Active Comparator: Healthy volunteers

Ultrasound measurements will be made while the upper back is at rest and during arm movements.

Device: Ultrasonographic measurements of the trapezius and rhomboid muscle and fascia

B mode measurements Trapezius and rhomboid muscle thickness and fascial thickness measurement M mode measurements Abduction at 90 and 180 degrees Forward flexion at 90 and 180 degrees

Outcome Measures

Primary Outcome Measures

Trapezius muscle and rhomboid muscle thickness [20 minute]
Trapezius and rhomboid muscle thickness and fascial thickness measurement will be made by ultrasonography at rest.
fascial slip [20 minute]
Measurements of the amount of slip measured during the movement of the fascial structures during shoulder and arm movements. ultrasonography M-mode measurements shoulder abduction at 90 and 180 degrees Shoulder forward flexion at 90 and 180 degrees

Secondary Outcome Measures

VAS [20 minute]
visual analog scale (VAS) :for pain. 0: no pain at all, 10: worst pain imaginable

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 50 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

18-65 years old
myofascial pain syndrome

Exclusion Criteria:

Cervical radiculopathy
Fibromyalgia
Shoulder joint disease,
Peripheral and central nervous system disease
Polyneuropathy,
Inflammatory rheumatic disease,
Malignancy

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

Bursa Yüksek İhtisas Education and Research Hospital

Investigators

Study Chair: Korgün Ökmen, Assoc. PhD., Bursa Yuksek Ihtisas Training and Research Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Dr. Burcu Metin Ökmen, Assoc.Phd.M.D, Bursa Yüksek İhtisas Education and Research Hospital

ClinicalTrials.gov Identifier:

NCT05359523

Other Study ID Numbers:

2021/10-16

First Posted:

May 4, 2022

Last Update Posted:

May 4, 2022

Last Verified:

Apr 1, 2022

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Myofascial Pain Syndromes

Fibromyalgia

Syndrome

Somatoform Disorders

Study Results

No Results Posted as of May 4, 2022